| Health / Medical Topics |
Recombinant human papillomavirus nonavalent vaccine
Pronunciation
A vaccine used to prevent anal, cervical, vulvar, and vaginal cancer caused by human papillomavirus (HPV) types 16, 18, 31, 33, 45, 52 and 58 and genital warts caused by HPV types 6 and 11. Recombinant human papillomavirus nonavalent vaccine is approved for use in males aged 9 to 15 years and females aged 9 to 26 years. It is a type of nonavalent vaccine (a vaccine that works against nine different viruses or other microorganisms). Also called Gardasil 9. (NCI Dictionary)
YOU MAY ALSO LIKE
A vaccine used to prevent cervical cancer caused by human papillomavirus (HPV) types 16 and 18. Recombinant human papillomavirus bivalent vaccine is…
A cancer vaccine containing autologous dendritic cells pulsed with a fusion product of an epitope of human tumor-associated epithelial mucin 1 (MUC1)…
A recombinant agent, chemically identical or similar to the endogenous small inducible cytokine A8 (MCP-2). This agent is a member of the…
A substance that causes blood stem cells (cells from which other types of cells develop) to change into different types of blood…
The recombinant form of endogenous MIP-1 beta chemokine that chemoattracts both neutrophils and monocytes, stimulates macrophages, and stimulates myelopoietic cell growth. …
A drug used to treat some types of cancer. It is a form of interleukin-2, a cytokine made by leukocytes (white blood…
